Rankings
▼
Calendar
NVCR Q4 2021 Earnings — NovoCure Limited Revenue & Financial Results | Market Cap Arena
NVCR
NovoCure Limited
$1B
Q4 2021 Earnings
Healthcare
Medical - Instruments & Supplies
Income Statement
Revenue
$133M
-7.5% YoY
Gross Profit
$104M
77.7% margin
Operating Income
-$23M
-17.6% margin
Net Income
-$26M
-19.9% margin
EPS (Diluted)
$-0.25
QoQ Revenue Growth
-0.3%
Cash Flow
Operating Cash Flow
$14M
Free Cash Flow
$130,000
Stock-Based Comp.
$22M
Balance Sheet
Total Assets
$1.1B
Total Liabilities
$729M
Stockholders' Equity
$410M
Cash & Equivalents
$210M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$133M
$144M
-7.5%
Gross Profit
$104M
$116M
-10.6%
Operating Income
-$23M
$12M
-293.5%
Net Income
-$26M
$5M
-638.1%
Geographic Segments
UNITED STATES
$92M
73%
GERMANY
$19M
15%
JAPAN
$9M
7%
CHINA
$6M
5%
← FY 2021
All Quarters
Q1 2022 →